|
[1]KANDA T,GOTO T,HIROTSU Y,et al.Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections:A review[J].Int J Mol Sci,2019,20(6):1358．
|
|
[2]THI VT,POOVORAWAN K,HAROEN P,et al.Association between hepatitis B surface antigen levels and the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection:Systematic review and Meta-analysis[J].Asian Pac J Cancer Prev,2019,20:2239-2246．
|
|
[3]LEE MH,YANG HI,LIU J,et al.Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients:Risk scores integrating host and virus profiles[J].Hepatology,2013,58(2):546-554．
|
|
[4]WONG KH,CHENG CY,LUNG Y,et al.Among patients with undetectable hepatitis B surface antigen and hepatocellular carcinoma,a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis[J].Clin Gastroenterol Hepatol,2020,18(2):449-456．
|
|
[5]CHEN YC,CHU CM,LIAW YF.Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B[J].Hepatology,2010,51(2):435-44．
|
|
[6]CHANG MH,HSU HY,HSU HC,et al.The significance of spontaneous hepatitis B e antigen seroconversion in childhood:With special emphasis on the clearance of hepatitis B e antigen before 3 years of age[J].Hepatology,1995,22(5):1387-1392．
|
|
[7]XIE YH.Hepatitis B virus-associated hepatocellular carcinoma[J].Adv Exp Med Biol,2017,1018:11-21:365．
|
|
[8]BUDZINSKA MA,SHACKEL NA,URBAN S,et al.Cellular genomic sites of hepatitis B virus DNA integration[J].Genes(Basel),2018,9(7)．
|
|
[9]WITJES CD,IJZERMANS JN,van der EIJK AA,et al.Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patients[J].Neth J Med,2011,69(11):508-513．
|
|
[10]CHEN X,WU F,LIU Y,et al.The contribution of serum hepatitis Bvirus load in the carcinogenesis and prognosis of hepatocellular carcinoma:Evidence from two meta-analyses[J].Oncotarget,2016,7(31):49299-49309．
|
|
[11]LIN CL,KAO JH.The clinical implications of hepatitis B virus genotype:Recent advances.[J].J Gastroenterol Hepatol,2011,26(Suppl 1):123-130．
|
|
[12]LIU CJ,KAO JH.Global perspective on the natural history of chronic hepatitis B:Role of hepatitis B virus genotypes A to J[J].Semin Liver Dis,2013,33(2):97-102．
|
|
[13]PINATO DJ,DALLA PRIA A,SHARMA R,et al.Hepatocellular carcinoma:An evolving challenge in viral hepatitis and HIV coinfection[J].AIDS,2017,31(5):603-611．
|
|
[14]RUGGIERI A,GAGLIARDI MC,ANTICOLI S.Sex-dependent outcome of hepatitis B and C viruses infections:Synergy of sex hormones and immune responses?[J].Front Immunol,2018,9:2302．
|
|
[15]BUETTNER N,THIMME R.Sexual dimorphism in hepatitis B and Cand hepatocellular carcinoma[J].Semin Immunopathol,2019,41(2):203-211．
|
|
[16]ZHA XD,LIU WB,CAO GW.Risk factors related to the sexual dimorphism in the incidence and prognosis of hepatocellular carcinoma[J].Shanghai J Prev Med,2017,29(4):253-256.(in Chinese)查旭东，刘文斌，曹广文．肝细胞癌发生及预后性别差异的相关危险因素[J]．上海预防医学，2017,29(4):253-256．
|
|
[17]YANG SJ,LI LJ,REN H.Epidemiology(8th edition)[M].Beijing:People's Medical Publishing House,2013.(in Chinese)杨绍基，李兰娟，任红．传染病学(第八版)[M]．北京:人民卫生出版社，2013．
|
|
[18]YIP TC,CHAN HL,WONG VW,et al.Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance[J].J Hepatol,2017,67(5):902-908．
|
|
[19]KIM GA,LEE HC,KIM MJ,et al.Incidence of hepatocellular carcinoma after HBs Ag seroclearance in chronic hepatitis B patients:Aneed for surveillance[J].J Hepatol,2015,62(5):1092-1099．
|
|
[20]LOOMBA R,LIU J,YANG HI,et al.Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma[J].Clin Gastroenterol Hepatol,2013,11(12):1636-1645.e1-3．
|
|
[21]WELEDJI EP.Familial hepatocellular carcinoma:'A model for studying preventive and therapeutic measures'[J].Ann Med Surg(Lond),2018,35:129-132．
|
|
[22]AN J,CHANG S,KIM HI,et al.The clinical behavior and survival of patients with hepatocellular carcinoma and a family history of the disease[J].Cancer Med,2019,8(15):6624-6633．
|
|
[23]LIN YJ,LEE MH,YANG HI,et al.Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients[J].PLo S One,2013,8(4):e61448．
|
|
[24]EL-ZAYADI AR.Heavy smoking and liver[J].World J Gastroenterol,2006,12(38):6098-6101．
|
|
[25]ALAVIAN SM,JAZAYERI SM.Commentary on“risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States”[J].Am J Gastroenterol,2012,107(4):635．
|
|
[26]LI Y,ZHANG Z,SHI J,et al.Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China[J].Int J Clin Exp Med,2015,8(1):1205-1212．
|
|
[27]IIDA-UENO A,ENOMOTO M,TAMORI A,et al.Hepatitis B virus infection and alcohol consumption[J].World J Gastroenterol,2017,23(15):2651-2659．
|
|
[28]LV X,LIU K,CHEN Y,et al.Analysis of risk factors associated with the development of hepatocellular carcinoma in chronic HBV-infected Chinese:A meta-analysis[J].Int J Environ Res Public Health,2016,13(6):604．
|
|
[29]LIN CW,LIN CC,MO LR,et al.Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis[J].J Hepatol,2013,58(4):730-735．
|
|
[30]WANG WJ,XIAO P,XU HQ,et al.Growing burden of alcoholic liver disease in China:A review.[J].World J Gastroenterol,2019,25(12):1445-1456．
|
|
[31]LINDENMEYER CC,MCCULLOUGH AJ.The natural history of nonalcoholic fatty liver disease-an evolving view[J].Clin Liver Dis,2018,22(1):11-21．
|
|
[32]TAN Y,ZHANG X,ZHANG W,et al.The influence of metabolic syndrome on the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection in Mainland China[J].Cancer Epidemiol Biomarkers Prev,2019,28(12):2038-2046．
|
|
[33]YU MW,LIN CL,LIU CJ,et al.Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B:A large cohort study[J].Gastroenterology,2017,153(4):1006-1017.e5．
|
|
[34]KUTLU O,KALELI HN,OZER E.Molecular pathogenesis of nonalcoholic steatohepatitis-(NASH-)related hepatocellular carcinoma[J].Can J Gastroenterol Hepatol,2018,2018:8543763．
|
|
[35]POLESEL J,ZUCCHETTO A,MONTELLA M,et al.The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma[J].Ann Oncol,2009,20(2):353-357．
|
|
[36]GOH MJ,SINN DH,KIM S,et al.Statin use and the risk of hepatocellular carcinoma in patients with chronic hepatitis B[J].Hepatology,2019.[Online ahead of print]
|
|
[37]ELKRIEF L,RAUTOU PE,SARIN S,et al.Diabetes mellitus in patients with cirrhosis:Clinical implications and management[J].Liver Int,2016,36(7):936-948．
|
|
[38]YOUNOSSI Z,KOCHEMS K,de RIDDER M,et al.Should adults with diabetes mellitus be vaccinated against hepatitis B virus?A systematic review of diabetes mellitus and the progression of hepatitis Bdisease[J].Hum Vaccin Immunother,2017,13(11):2695-2706．
|
|
[39]LI X,XU HQ,GAO PJ.Diabetes mellitus is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection in China[J].Med Sci Monit,2018,24:6729-6734．
|
|
[40]CHEUK-FUNG YIP T,WAI-SUN WONG V,LIK-YUEN CHANH,et al.Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen[J].Clin Gastroenterol Hepatol,2018,16(5):765-773.e2．
|
|
[41] CHEN HJ,ZHONG NS,LU ZY.Internal medicine(8th edition)[M].Beijing:People's Medical Publishing House,2013.(in Chinese)陈灏珠，钟南山，陆再英．内科学(第八版)[M]．北京:人民卫生出版社，2013．
|
|
[42]LI M,NIE QH,HAN M,et al.Risk factors,early screening,and preventing strategy for hepatitis B-related hepatocellular carcinoma[J].J Clin Hepatol,2019,35(3):651-655.(in Chinese)李汨，聂青和，韩曼．HBV相关肝细胞癌的危险因素、早期筛查和预防策略[J]．临床肝胆病杂志，2019,35(3):651-655.
|
DownLoad: